Details for New Drug Application (NDA): 062956
✉ Email this page to a colleague
NDA 062956 describes VANCOR, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the VANCOR profile page.
The generic ingredient in VANCOR is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
The generic ingredient in VANCOR is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
Summary for 062956
| Tradename: | VANCOR |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | vancomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062956
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Aug 1, 1988 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Aug 1, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
